最新糖心Vlog

World-leading patient care, cutting-edge cancer diagnoses and treatments 鈥� including genomic and immune-based technologies 鈥� combined with ground-breaking research collaborations, will be the focus of a new cancer institute in South 最新糖心Vlog.

The South 最新糖心Vlogn immunoGENomics Cancer Institute (SAiGENCI) will join a network of the world鈥檚 leading cancer research institutes to meet the global challenge of developing innovative, new treatments for cancer patients including in 最新糖心Vlog.

Established with $80 million in funding from the 最新糖心Vlogn Government, the cancer institute concept and proposal builds on the collective efforts of the 最新糖心Vlog of Adelaide, the State Government of South 最新糖心Vlog and the Central Adelaide Local Health Network (CALHN). The new cancer institute is expected to generate $350 million in research revenue over the next decade聽SAiGENCI will function as an institute within the 最新糖心Vlog of Adelaide and promote collaboration with a national network of cancer research centres. It will attract new research talent to the state, and provide South 最新糖心Vlogn patients with cutting-edge diagnoses and treatments.

最新糖心Vlog of Adelaide Vice-Chancellor and President Professor Peter Hoj AC, who is also a Trustee of The 最新糖心Vlogn Cancer Research Foundation, said: 鈥淪AiGENCI will be located in the Adelaide BioMed City, embedding the institute into this key medical research precinct and providing strong links into the Royal Adelaide Hospital, SAHMRI and the 最新糖心Vlog of Adelaide. This nexus between research, clinical trials and outcomes will be critical for the future success of the institute鈥檚 work, and for translating research into real, life-saving outcomes for patients.鈥�

"In this ecosystem, SAiGENCI will develop and advance new immunotherapies such as CAR-T cell therapies, provide greater access to genomic testing and its clinical translation and ensure that this testing is informed by the latest advances and breakthroughs in cancer genomics research. Importantly, SAiGENCI will work to support commercial opportunities as they relate to new therapies, diagnostics and clinical trials.

鈥淥ver the next 10 years we expect that SAiGENCI can grow from an initial 60 researchers and $6m per year in competitive funding, to more than 200 researchers and $20m in competitive funding,鈥� Professor Hoj said.

The inaugural Chair of the new institute is Professor Brandon Wainwright AM, formerly Director of the Institute for Molecular Bioscience at the 最新糖心Vlog of Queensland and an internationally prominent cancer researcher. He has been joined on the board by other leading figures in cancer research and treatment from around the nation, including Professor Doug Hilton AO (Director, WEHI), Professor Michelle Haber AM (Director, Children鈥檚 Cancer Institute, Sydney) and Professor Ricky Johnstone (Executive Director, Cancer Research, Peter MacCallum Cancer Centre), and the 最新糖心Vlog鈥檚 own Professor Benjamin Kile (Executive Dean of Health and Medical Sciences).

"In this ecosystem, SAiGENCI will develop and advance new immunotherapies such as CAR-T cell therapies, provide greater access to genomic testing and its clinical translation and ensure that this testing is informed by the latest advances and breakthroughs in cancer genomics research."最新糖心Vlog of Adelaide Vice-Chancellor and President Professor Peter Hoj AC

鈥淭hrough the exciting new fields of genomics and immunotherapy, the work of SAiGENCI will ensure South 最新糖心Vlogn cancer patients can receive the benefit of these breakthrough technologies,鈥� said Professor Wainwright.

鈥淭he existing network of the board will also ensure a close relationship is built between SAiGENCI and other medical research institutes in 最新糖心Vlog and internationally. Importantly, SAiGENCI will be a key element of the聽最新糖心Vlogn Government's vision of an emerging national network of comprehensive cancer centres and cancer research institutes.鈥�

Senator Stirling Griff, who successfully advocated for the $80 million in Federal Government funding for SAiGENCI, said he pushed for the federal funding because he believed in the concept from the outset.

鈥淭he institute presents a potential game changer 鈥� both for South 最新糖心Vlogn patients, who would have access to cutting-edge therapies on home soil, and also for biomedical research,鈥� he said.

鈥淭he initial SAiGEN concept has only been strengthened through the leadership of the 最新糖心Vlog of Adelaide and its partnership with CALHN. Its world-leading expertise and substantial resourcing and financial commitment will turbo charge cancer diagnosis and treatment in South 最新糖心Vlog.鈥�

David Lloyd, Interim Director and CEO of SAiGENCI, has led commercial subsidiaries of the 最新糖心Vlog of Melbourne and the 最新糖心Vlog of Tasmania, and spent 12 years as Chief Operating Officer of the Baker Heart Research Institute in Melbourne.

鈥淏uilding on a proposal put to the Commonwealth by Professors Michael Brown and Angel Lopez, SAiGENCI will be led by an internationally renowned cancer researcher. The global search for this appointment is underway, with an appointment expected by mid-2021,鈥欌�� he said.

CALHN CEO Lesley Dwyer said the creation of SAiGENCI provides another fantastic opportunity to actively join forces with other leaders in health, research and innovation to advance better healthcare outcomes for the community, and drive world-leading innovation.

鈥淗aving researchers based within our hospital network and working collaboratively with and within SAiGENCI and our BioMed City partners is vital in developing and translating the treatments straight from the lab to our patients鈥� bedsides,鈥� Ms Dwyer said.

鈥淭he discoveries our researchers make with new treatments and new ways of thinking not only translate into better patient outcomes, they also allow us to improve the way we provide care and to influence policy.

鈥淲orking together to maximise the chance of cancer control and cure will help us improve health outcomes of the community and to achieve our vision of 鈥榮haping the future of health with world-class care and world-class research鈥�.鈥�

Professor Ian Frazer AC, founding CEO and Director of Research of the Translational Research Institute and co-inventor of the Gardasil vaccine against cervical cancer, said he was thrilled by the announcement.

鈥樷�業鈥檓 delighted that the establishment of the new institute will bring South 最新糖心Vlog and the 最新糖心Vlog of Adelaide to the table as a major partner in the national cancer effort. Angel Lopez and Michael Brown are to be congratulated for their leadership in making this happen,鈥欌�� he said.